LIDE Biotech

We’re proud to share that LIDE Biotech has successfully completed VERIF.i® on-site assessments at two of our China-based facilities—Shanghai and Xi’an. VERIF.i is Scientist.com’s on-site pre-assessment program that helps suppliers of regulated services demonstrate the quality and standards of their laboratories to both existing and prospective clients. Thank you for the continued support and partnership from the team at Scientist.com ! “We’ve adopted the highest global operational standards at LIDE, ensuring our facilities and processes not only meet but surpass industry expectations,” stated Dr. Danyi Wen, President and CEO of LIDE Biotech. “VERIF.i is one more way to demonstrate our commitment to quality and compliance to our biotech and pharmaceutical clients globally.”

LIDE will be attending the 2024 American Association for Cancer Research conference in San Diego next week! We'd like to invite you to our booth to meet our Founder & CEO, Dr. Danyi Wen along with our US leadership team. LIDE will also have 4 posters you don't want to miss which will include: 1. Improved PBMC humanized mouse models for immuno-oncology drugs evaluation 2. Reverse engineering strategy for new targets identification 3. PMed-TRIAL PDX database: Integrated multidimensional information to facilitate new drug development 4. Application of MiniPDX® in clinical indication identification and anti-tumor drug development Looking forward to seeing you over the next week. If you're interested in setting up a private meeting with our team, please contact our Global VP of BD & Client Relations, Josh Caggiula at [email protected] Also please add the LIDE Exhibitor Booth 2924 to your AACR Annual Meeting show planner by following this link: https://lnkd.in/ejVt7kfH

For the 2nd event in the Animal Welfare Legislation series, we will focus on the Asia Pacific region, uncovering the landscape of animal welfare legislation and its implications for pharmaceutical and biotech professionals. We will be joined by Meaghan Loy, MS, ALAT and Dr. Danyi Wen, President, Founder & CEO of LIDE Biotech. https://bit.ly/3v4iVll #animalwelfare #biotech #pharma

At LIDE, we want to take this moment to wish you and your loved ones a joyous and healthy holiday season. As we turn the calendar from 2023 to 2024, we wish you peace and prosperity in the new year. As always, we appreciate and value the trust our clients place with us. We are looking forward to 2024, a year we expect to bring continued innovation and support to the development of new oncology therapeutics and improving the lives of people with cancer.   If you're interested in connecting with our team in person in early 2024, LIDE will be at the 8th Tumor Models San Francisco in January and AACR in April San Diego in April. Please contact our Global VP of BD & Client Relations, Josh Caggiula ([email protected]) and he can arrange a time for us to all meet.    Warm Regards, Danyi Wen Founder, President & CEO

LIDE is a proud sponsor of the 12th Annual Tumor Models London Summit next week? Join LIDE, along with other leaders in drug discovery and preclinical innovation to discuss how new technology and tools can accelerate and optimize your translation into clinical assets. There are some free tickets still available for biopharma and academia researchers, you can secure your spot here: https://tumour-models.com/ #TumorModels #CancerResearch #RareCancers #MetastaticCancers #TranslationalOncology #TML23 #pdxmodels

Our Global VP of Client Relations Josh Caggiula is LIVE from the 2023 ESMO - European Society for Medical Oncology in Madrid, Spain! We’re on Day 3 of the conference having great conversations with clients, colleagues, and friends from all around the world. Come visit LIDE Biotech at Booth # 547 (near the GSK booth). Our Global BD leaders are there to discuss your preclinical oncology study needs and how LIDE’s platform can help accelerate your research and improve translation to the clinic! Please come visit if you’re here this week! #esmo23 #esmo2023 #oncologyresearch #cancerresearch

Our 2023 Fall road trip continues to the Sino-American Pharmaceutical Professionals Association (SAPA) Annual Confernce in New Brunswick, NJ! Happy 30th anniversary to SAPA and thank you for your warm welcome into your community the past 2 years. Cheers to many more years! 🥂 LIDE Biotech Loc Van

Honored to be attending the #RAS -Targeted Drug Development conference in Boston this week. Exciting to hear some of the latest developments from the leading minds researching the ras pathway. If you or your colleagues are researching this pathway, at LIDE Biotech we have over 100 KRAS mutation PDX models available to support your preclinical drug programs. Reach out for access to our new online PMed-TRIAL database or sign up at: pmed.lidebiotech.com:8000

We're excited to be an Event Partner at the upcoming 5th Annual RAS-Targeted Drug Development Summit to discuss the latest developments and targets relating to the RAS pathway. With over 104 KRAS mutation models in our library, we offer your research team access to the models and support for your novel drug development strategies. Stop by our exhibit booth to talk to a member of the LIDE team about how our platform can validate and accelerate your RAS-targeted compounds. Hope to see you there! If you'd like to arrange time to meet with a member of our team in advance at the event or in the Boston area, contact our VP of Global BD & Client Relations Josh Caggiula at [email protected] Event registration: https://lnkd.in/d-29jaH